project id: TCGA-SKCM; case submitter id: TCGA-FR-A7U8; source center: 23; state: released; a260 a280 ratio: 1.8; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.01; age at index: 50; days to birth: -18346; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1962; age at diagnosis: 18346; ajcc pathologic m: M0; ajcc pathologic n: N3; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: TX; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 847.0; icd 10 code: C17.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: Yes; progression or recurrence: not reported; site of resection or biopsy: Small intestine, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 407; days to sample procurement: 0; portion submitter id: TCGA-FR-A7U8-06A-21; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 20.0; percent stromal cells: 10.0; percent tumor cells: 60.0; percent tumor nuclei: 70.0;